Publications
Résultats 431 à 440 sur 558 Publications
| Titre | Auteurs | Année | Revue |
|---|---|---|---|
| Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy | Beaudin, A. E.**, McCreary, C. R., Mazerolle, E. L., Gee, M., Sharma, B.**, Subotic, A., Zwiers, A. M., Cox, E., Nelles, K., Charlton, A., Frayne, R.*, Ismail, Z.*, Beaulieu, C.*, Jickling, G., Camicioli, R. M.*, Pike, G. B.*, & Smith, E.* | 2022 | Neurology |
| Cerebrovascular damage after midlife transient hypertension in non-transgenic and Alzheimer’s disease rats | Lai AY, Loo IL, Trivedi AU, Dorr A, Hill ME, Stefanovic B*, McLaurin J* | 2021 | Brain Research |
| Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E | Robert J, Button EB, Martin EM, McAlary L, Gidden Z, Boyce G, Caffrey TM, Agbay A, Clark A, Silverman JM, Cashman NR*, Wellington CL* (Team 3) | 2020 | Molecular Neurodegeneration |
| Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer’s disease | Ashton, N. J., Benedet, A. L., Pascoal, T. A.**, Karikari, T. K., Lantero-Rodriguez, J., Brum, W. S., Mathotaarachchi, S., Therriault, J., Savard, M., Chamoun, M., Stoops, E., Francois, C., Vanmechelen, E., Gauthier, S.*, Zimmer, E. R., Zetterberg, H., Blennow, K., & Rosa-Neto, P.* | 2022 | EBioMedicine |
| Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study | Foley MK, Searle SD, Toloue A, Booth R, Falkenham A, Falzarano D, Rubino S, Francis ME, McNeil M, Richardson C, LeBlanc J, Oldford S, Gerdts V, Andrew MK*, McNeil SA, Clarke B, Rockwood K*, Kelvin DJ, Kelvin AA | 2021 | Eclinical Medicine |
| CCCDTD5: research diagnostic criteria for Alzheimer’s Disease | Gauthier S*, Chertkow H*, Theriault J, Chayer C, Ménard MC, Lacombe G, Rosa-Neto P*, Ismail Z* | 2020 | Translational Research & Clinical Interventions |
| CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia | Rockwood K*, Andrews MK*, Aubertin-Leheudre M, Belleville S*, Bherer L*, Bowles SK, Kehler DS, Lim A*, Middleton L*, Philips N*, Wallace LK | 2020 | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| CCCDTD5: Individual and community‐based psychosocial and other non‐pharmacological interventions to support persons living with dementia and their caregivers | Vedel I*, Sheets D, McAiney C*, Clare L*, Brodaty H, Mann J, Anderson N*, Liu-Ambrose T*, Rojas-Rozo L, Loftus L, Gauthier S*, Sivananthan S | 2020 | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment | Brisson M, Brodeur C, Létourneau-Guillon L, Masellis M*, Stoessl J*, Tamm A, Zukotynski K, Ismail Z*, Gauthier S*, Rosa-Neto P*, Soucy JP* | 2021 | Alzheimer's & Dementia |
| CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus | Montero-Odasso M*, Pieruccini-Faria F**, Ismail Z*, Li, K*, Lim A*, Philips N*, Kamkar N, Sarquis-Adamson Y, Speechley M*, Theou O*, Verghese J, Wallace L, Camicioli R* | 2020 | Translational Research & Clinical Interventions |
Résultats 431 à 440 sur 558 Publications